<SEC-DOCUMENT>0000731766-23-000038.txt : 20230525
<SEC-HEADER>0000731766-23-000038.hdr.sgml : 20230525
<ACCEPTANCE-DATETIME>20230525110255
ACCESSION NUMBER:		0000731766-23-000038
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230525
DATE AS OF CHANGE:		20230525

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNITEDHEALTH GROUP INC
		CENTRAL INDEX KEY:			0000731766
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				411321939
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10864
		FILM NUMBER:		23957602

	BUSINESS ADDRESS:	
		STREET 1:		UNITEDHEALTH GROUP CENTER
		STREET 2:		9900 BREN ROAD EAST
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55343
		BUSINESS PHONE:		9529361300

	MAIL ADDRESS:	
		STREET 1:		9900 BREN ROAD EAST
		CITY:			MINNETONKA
		STATE:			MN
		ZIP:			55343

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP/
		DATE OF NAME CHANGE:	20000309

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>unh2023defa14a-iss.htm
<DESCRIPTION>DEFA14A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i9a292659f1c44d6b894fa40bfc6b59aa_1"></div><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.188%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="margin-top:0.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="margin-top:0.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SCHEDULE 14A</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proxy Statement Pursuant to Section 14(a) of</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">the Securities Exchange Act of 1934 (Amendment No.  )</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Filed by the Registrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Filed by a party other than the Registrant&#160;&#160;&#160;&#160;&#9744;</font></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Check the appropriate box&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preliminary Proxy Statement</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definitive Proxy Statement</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definitive Additional Materials</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Soliciting Material under &#167;240.14a-12</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 10pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">UnitedHealth Group Incorporated</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000;padding:2px 10pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Name of Registrant as Specified In Its Charter)</font></td></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="6" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:1pt solid #000;padding:2px 10pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of Filing Fee (Check the appropriate box)&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">No fee required.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fee paid previously with preliminary materials.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.188%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><img alt="uhgr_cmyka.jpg" src="uhgr_cmyka.jpg" style="height:50px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">UnitedHealth Group Incorporated Supplemental Proxy Materials </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">For the Annual Meeting of Shareholders on June 5, 2023</font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">May 25, 2023</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Deliver to&#58; Kathryn Cohen </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Head of the Research Helpdesk</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Institutional Shareholder Services</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Dear Ms. Cohen,</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">We are writing regarding your recommendation of a &#8220;for&#8221; vote on Proposal 7 in our 2023 Proxy Statement &#8211; Shareholder Proposal Seeking Shareholder Ratification of Termination Pay. We believe there is a flaw underlying your recommendation, along with an important omission of fact, and would request that you urgently review and change your recommendation to be &#8220;against&#8221; the proposal.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The conclusion of your analysis on page 34 of the report states&#58;</font></div><div style="margin-top:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The company maintains a severance policy that establishes a reasonable limit on cash severance. However, the proxy does not disclose a clear requirement that shareholder approval is required for payments in excess of the maximum severance provided under the policy. Without such a requirement, shareholders do not have sufficient assurances against excessive severance payments (or payments that exceed market norms) that could be made at the discretion of the committee, without requiring shareholder approval.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Here is why we believe this to be problematic&#58;  </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">On page 80 of the Proxy, we state&#58; &#8220;We have a policy that we will not pay cash severance to executive officers exceeding 2.99x the sum of base salary and bonus.&#8221;  Later on the same page we state, &#8220;Our Compensation and Human Resources Committee has adopted a policy which sets forth that we will not pay cash severance exceeding 2.99x the sum of base salary and bonus to executive officers, rendering the adoption of the proposal unnecessary.&#8221;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">We do not believe there is any meaningful difference between a policy not to do something, and a policy not to do it without shareholder approval. In our view the categorical nature of the policy, not qualified by an exception based on obtaining shareholder approval, provides at least as much assurance that safeguards against excessive severance payments as a policy that does have the qualification. As a technical matter, we would note that including a reference to shareholder approval gives no more assurance than not including it, since a Board would still be free to change the policy at its discretion.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As to the omission, you state in your conclusion, &#8220;Further, the proposal only applies to future severance arrangements, current agreements will not be affected.&#8221;  However, our policy is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> to pay cash severance exceeding 2.99x the sum of base salary and bonus to executive officers, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">regardless of when the severance arrangement was entered into</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">. And, in fact, all our existing arrangements provide for cash severance of 2x, not 2.99x base salary and bonus. Consequently, our policy is STRONGER than the proposal in applying to ALL severance arrangements for executive officers, current and future, and in being categorical that the cap will not be exceeded.</font></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">That having been said, we are pleased that your report acknowledges that our policy limit on cash severance is a reasonable one. Second, we are also pleased by your acknowledgement that &#8220;shareholders may consider the proposal's inclusion of equity awards within the calculation of severance is not in line with established market norms&#8221;. All shareholders we spoke to in the pre-Proxy consultation were comfortable with the acceleration of equity awards in the very limited circumstances of termination on death, disability or the &#8220;double trigger&#8221; following a change of control, and that the value of that equity acceleration not be included in the severance cap.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">In light of these factors, we respectfully request that you reconsider your position and change your recommendation to vote against the proposal.</font></div><div style="margin-top:9pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">Sincerely,</font></div><div style="margin-top:24pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#47;s&#47;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Rupert M. Bondy</font></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>uhgr_cmyka.jpg
<TEXT>
begin 644 uhgr_cmyka.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  2     $  0!(     0 !_^(,6$E#0U]04D]&24Q%  $!   ,2$QI
M;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0     245#
M('-21T(                  /;6  $     TRU(4" @
M                                               18W!R=    5
M   S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA96@
M A@    49UA96@   BP    48EA96@   D     49&UN9    E0   !P9&UD
M9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4
M;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P
M  @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W
M;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y
M-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                     %A96B
M      #S40 !     1;,6%E:(                     !865H@
M;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@   /
MA   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M     !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                    9&5S8P         N245#(#8Q
M.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M       N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="                             &1E<V,         +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M     "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ                                  !V:65W       3I/X %%\N
M !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?YVUE87,
M         0                        */     G-I9R      0U)4(&-U
M<G8        $      4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\
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M[D(P0G)"M4+W0SI#?4/ 1 -$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T?
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M^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X $T%D;V)E &0
M     04  DE$_]L A  " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%
M!04%!04%!P@(" <%"0H*"@H)# P,# P,# P,# P,# P, 0," @,# P<%!0<-
M"PD+#0\-#0T-#P\,# P,# \/# P,# P,#PP.#@X.#@P1$1$1$1$1$1$1$1$1
M$1$1$1$1$1'_P  1" !% 9@# 1$  A$! Q$!_\0!H@    <! 0$! 0
M    ! 4# @8!  <("0H+ 0 " @,! 0$! 0         !  (#! 4&!P@)"@L0
M  (! P,"! (&!P,$ @8"<P$" Q$$  4A$C%!408382)Q@10RD:$'%;%"(\%2
MT>$S%F+P)'*"\25#-%.2HK)C<\(U1">3H[,V%U1D=,/2X@@F@PD*&!F$E$5&
MI+16TU4H&O+C\\34Y/1E=865I;7%U>7U9G:&EJ:VQM;F]C='5V=WAY>GM\?7
MY_<X2%AH>(B8J+C(V.CX*3E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^A$
M @(! @,%!00%!@0( P-M 0 "$0,$(1(Q0051$V$B!G&!D3*AL? 4P='A(T(5
M4F)R\3,D-$."%I)3):)CLL('<](UXD2#%U23" D*&!DF-D4:)V1T53?RH[/#
M*"G3X_.$E*2TQ-3D]&5UA96EM<75Y?5&5F9VAI:FML;6YO9'5V=WAY>GM\?7
MY_<X2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H
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M )S+\I>>_P#G(WS+_P X\:?Y2U2UOO+]UJVG+K<LL1AGO-%+K=H;<#DB<H9
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M@&9_8<)3[!G&(LD3 ^UUOM#DC#VBQRD: ,"3\0_6_P#Z&F_YQO\ _+X^2O\
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MW*L&I/I=M'8W"FG<2VS C-#VWCE#M#*#_.)^9MZ/L#+')V;A(_F@?(4^*?\
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M>,"BG=(FI\(V7MG8^U_H[-Q0/.Q]D2\/[%?O.ULTX\J/VR%(+\K/_DI^J?\
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MNK@K5J!I'/%23Q0*M32N:'M/7SUFIEEEU^P='HNRNSH:'2QPQZ=>\]2^0_\
MG#G_ )QU_-/\G_SB_/WS7Y[T>UTW0?-EVR:)<PWL%R;Z-[ZYN?62.%W=%",M
M1*J-4_9ZTVG;_:VFU6DPPQG<#?;EL'4^SG8VJT>LSSR"A([;\]R6)_\ .>O_
M #B5^8/YL^9/*WYF?DOHJZKYL^HS:!YALX[RUT^2>S*2"&X$EW/;1M\$LD,@
MY<BI04*J:6^R_;N#2XY8LYJ-V-B=_@T^UOL]J-7DCFTXN5418&WQI[5_S@1^
M2_Y@_D;^3&L^6/S+TF'0O,.L^;;W6DL8[J"\:*VDL]/M8_5DMI)HN3-9LU%=
MOA*UHU5&)[4=HX-9JQ/$; B!?+J3^ES/9'LO4:'1&&843(FKOH!T]SPC2_\
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M,L5P=2O[.[M#<Q,L3&#T5M=8U!F8R!10Q\>-:L-LU':6G[%C@)P9)&70;_I
M=UV5J>WIZ@#48HB'4@B_LD7R[^<7_..7_.3^F?\ .8FK?G]^5WY;6'G?2H-2
MLM6TMI]7TZUAD:+3X;5XIXKF^LY@59&K04Z48YLNS^UNSI=DC3Y9F)H@[$];
MZ NL[2[&[3AVR=5AQB0L$;@=*ZD,]_,*\_Y^4?FWH=_Y%_Y59Y6_*S0O,%N]
MGJ&IV6K6$ER;>8%)HS,-6OW1'5J$QP\Z5HV4:2/L_I9C)XDID<A1_4/O;]9/
MVDU<#C&., >9L7]Y^Y].?\XB_P#.+>G_ /.,ODO4K&ZU.'S#YX\US0W.NZG;
MH4MP(%806EL' <Q1>HYY, SLQ8A1Q5==V]VU+M',#51'(?I=G[.]@Q[,P&-W
M(\S^@/F7\XO^<5_SB\Z?\YQ^1?SAT31;.3\N--U?ROK%[J\E_;Q_5TT-X)+B
M!K9I!<-(_P!5HG"-D^)>3+\7'8]G=MZ7#V//#(^LB0 K^=YNM[3[ U>?MS'G
MB!P Q)-_S?+F_5#.;>H?E?\ D[_SBO\ G%Y+_P"<X_/7YPZWHMG'^7&I:OYH
MUBRU>._MY/K":X\\EO MLLAN%D3ZU1^<:I\+<6;X>72=H]MZ7-V/##$^L"((
MK^;YO+]F=@:O!VYDSR X"9$&_P"=Y<U7_GX3_P XU?G)^>/F7\N=:_*WRK'Y
MHMM"TR\LKY/TA8V4D,DLR2(U+ZXME92 ?LDFO48^RG;&DT<)QRRJR*V)^Y?;
M+L/6:Z>.6&-T#>X'WTMM/.O_ #]'L[6VM(OR2\F&*UB2%.5WI1/%%"BI_P 2
MC>@Q.F]G";\67R/_ !*!J_:D"O!C\Q_Q3Z&OV_YRD\X_\XI>?-/\U>2=,TG\
M^]>L;_2+/2=)OK2.)K6\E6W$PG:]FMXY!;RR,/WYW5356/$8$1V=B[3@82)Q
M @V0?U.RD>U,W94Q. &4@B@1^LCEYL?_ .<1?^<3=$_*O\G[+2/S5\C^7-;\
M_:SJ%QJNI_7;6TU1K,2B.*&T6X>.12$CA4L$)3FS<2P^(S[?[<EJM698I$1
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M'EG0ZW4]B=J 3G,PE^.>Q!>9[/TO;_9!./' 3A[_ +MP0D/Y@_E%_P YB_\
M.5_YL>1_-/GK\G[#\N+'RLMK8O=-.MO!%:)=&XDD=)KVXFE>LC4$:=*#WR>E
MU_979NEG#'E,B?U>YCK.SNV.U=9CGDQ" C77SOO?='_.?/Y-?F'^>'Y,Z%Y7
M_+/1(_,'F#2?-]EK$MD]W;69:UBL=2MG9)+N6"*H>[0T+C:M*G;-/[+=HX-'
MJS/*:!B1W]0>GN=S[7]F:C7:(0PBR) U==".OO>O?DE^5]UHG_..'DC\IOS'
MTB![A/*@T37],,B3Q<;F-TN+=I(F9&^&0J2I(KT)ZYB=HZT3U\\V,_Q6"YO9
MFA,.SH8<H_AHC[WQK_SA[_SC[_SD'_SC=^=WGKR]?:&NI_D7YD%S''KGZ2L6
M#O:%GTV\%FMQ]865T8Q2KZ0%6K4JBD[;V@[5T/:&CA(&L@Z4?B+=-[-]C]H=
MFZW) B\1ZV.G(US]^R9?\Y4_\XE?F7J'YM:/_P Y)_\ ..MQ;+^8>FS6MUJ.
MC32QVS75U9J(DN8))6CA;U(5$<T3LH8 FI+$9'L3MW3QTITNI^@\CW6S[?\
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!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
